Nobilis EDS

Država: Nova Zelandija

Jezik: angleščina

Source: Ministry for Primary Industries

Aktivna sestavina:

egg drop syndrome virus

Dostopno od:

Schering-Plough Animal Health Limited

INN (mednarodno ime):

egg drop syndrome virus

Sestava:

egg drop syndrome virus 0 vaccine

Terapevtsko območje:

Vaccine

Status dovoljenje:

ACVM Registered

Datum dovoljenje:

1998-09-09

Lastnosti izdelka

NOBILIS EDS
500 mL (1000 doses) – Leaflet, Carton and Label
A007610
Page 1 of 5
NOBILIS EDS
28-Oct-21
Leaflet
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
NOBILIS
®
EDS
Inactivated vaccine for the protection of chickens against Egg Drop
Syndrome ’76.
DESCRIPTION
Nobilis EDS contains one immunogenic strain of EDS ’76 virus and is
inactivated with formalin.
Subsequently it has been suspended in the aqueous phase of an oil
adjuvant emulsion.
COMPOSITION
Active component per 0.5 mL dose: EDS ’76 virus strain BC14;
inducing

6.5 log
2
HI units.
INDICATION
Active immunisation to provide protection against Egg Drop Syndrome
’76.
RECOMMENDED VACCINATION PROGRAMME
Nobilis EDS should be administered to birds from 16-20 weeks of age
but not less than 4 weeks
before the expected onset of lay.
Duration of immunity: one laying period.
DOSAGE AND ADMINISTRATION
BY LAW THE USER MUST TAKE DUE CARE, OBTAINING EXPERT ADVICE WHEN
NECESSARY, TO AVOID
UNNECESSARY PAIN AND DISTRESS WHEN USING THE PRODUCT OTHER THAN AS
DIRECTED ON THE LABEL.
Each bird should be injected with 0.5 mL of vaccine intramuscularly in
the thigh or chest muscle or
subcutaneously into the lower part of the neck.
•
Vaccinate healthy birds only.
•
Before using vaccine allow it to reach ambient temperature (15

C-25

C).
•
Shake the bottle well before use and periodically during use.
•
Use sterile injection equipment.
•
Use the entire contents when first opened.
•
Do not mix with any other veterinary medicines.
VACCINATION REACTIONS
In healthy birds no clinical reaction to vaccination will be observed.
For some weeks after
vaccination a slight swelling may be felt at the site of vaccination.
Local tissue reactions may
occur.
WITHHOLDING PERIODS
Nil.
HANDLING PRECAUTIONS
ACCIDENTAL SELF-INJECTION
TO USER
This product contains mineral oil. Accidental self-injection may
result in severe pain and swelling,
particularly if injection into a joint of a finger. In rare cases this
could result in the loss of the
30/05/2022
NOBILIS